Reditux 500 mg Injection
  1. Home
  2. Pharma Products
  3. Dr Reddy 's Laboratories Ltd
  4. Reditux 500 mg Injection

Reditux 500 mg Injection

Reditux 500 mg Injection contains rituximab 500 mg, a monoclonal antibody used to treat certain blood cancers and autoimmune conditions. It is supplied as a concentrate for solution for intravenous infusion and must be administered by a healthcare professional. Rituximab targets CD20-positive B cells to help control abnormal cell activity.

BUY NOW

Category

Reditux 500 mg Injection is used in conditions such as non-Hodgkin lymphoma and chronic lymphocytic leukemia, with additional indications including rheumatoid arthritis and certain vasculitic disorders. Rituximab is an anti-CD20 monoclonal antibody that binds to CD20 on B lymphocytes and promotes their depletion. The dosage and infusion schedule are determined by the treating specialist according to the indication and treatment protocol. Reditux 500 mg is marketed by Dr. Reddy’s Laboratories Ltd. and is supplied as a 50 mL vial containing 500 mg rituximab.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 500 mg
Dosage Form Concentrate for Solution for Infusion
Concentration 10 mg/mL
Route of Administration Intravenous Infusion
Pack Size 50 mL Vial

Product Also Known As

Reditux 500 mg Injection, Reditux 500 Injection, Reditux Rituximab 500 mg, Rituximab 500 mg Injection, Rituximab 500 mg/50 mL, Anti-CD20 Monoclonal Antibody Injection